Funding Opportunities
Internal and external funding opportunities collected by the CTSI.
CTSI PilotsThe Translational Pilot Program will solicit, review and award pilot grants designed to produce and test novel tools and methods to bridge translational gaps. |
Ignition FundsProviding ignition funding to accelerate progress for clinical and translational research projects. |
K12 FundingProviding 2-3 years of support for early-career research faculty from Wake Forest. |
Community Partnered Research AwardCommunity Engagement provides funding to support community and academic researchers via the Community Partnered Research Award. |
Special Populations Voucher FundsStudies that identify a financial need can request funds from the voucher program to help overcome barriers related to transportation, child care, etc. |
Team Grant AcceleratorSupporting planning, pre-award, and post-award stages to incentivize investigators to pursue new large awards. |
Internal
Recurring Funding Opportunities:
- CTSI - Translational Pilot Program Ignition Funds - Deadline: 12/03/24
- CTSI - Research Salary Bridge Funding - Deadline: 01/01/25
- CTSI - Early Career Salary Support - Deadline: 01/01/25
School of Medicine and Advocate Health 2024 Requests For Proposals
The WFU Program for Leadership and Character invites proposals from any WFU School of Medicine or AHWFB or Advocate Health System employee with ideas for character development programs for current and/or future clinicians (i.e. students) and/or care team members.
Character in Medicine Grant
The Character in Medicine Grant exists to empower employees of the Wake Forest University and Advocate Health System to design, implement, and/or more rigorously assess educational programs that promote participants’ character development. This grant will fund proposals to launch pilot projects, revise existing programs, and/or implement research and/or assessment on programs to better understand their character growth impacts. Funding amount will vary from $1,000 to $30,000. Projects costing above $7,500 require a preliminary discussion with Elizabeth Whiting and/or Lauren Iley-Spear.
Applications will be accepted on a rolling basis between May 2024 – August 2025. Faculty or staff from The Wake Forest University School of Medicine and Advocate Health System are encouraged to apply. Estimated time required to complete application: 30+ minutes. Download Character in Medicine Grant Application.
Contact Elizabeth Whiting or Lauren Iley-Spear with questions.
December Deadlines
Center for Redox Biology and Medicine Pilot RFA
The Center for Redox Biology and Medicine (CRBM)is seeking proposals for projects in need of support to advance research in redox biology and medicine aligned with the strategic areas of emphasis of our institution. Successful pilots will receive up to $20,000, to be spent within a 12-month project period.
These awards are open to investigators with faculty rank across the Southeast region of Advocate Health. This includes Atrium Health, Atrium Health Navicent, and Atrium Health Wake Forest Baptist, including Wake Forest University School of Medicine. Collaborative projects involving other institutions such as Wake Forest University must include as PI or co-PI investigators at Advocate Health and/or Wake Forest University School of Medicine with a substantial, direct role on the project.
Additional details are available in the RFA. Applications should be submitted through the ePilot electronic submission system.
Full Application Deadline: December 5, 2024 at 11:59PM ET
Center for Addiction Research Pilot RFA
The Center for Addiction Research (CFAR) is seeking proposals for pilot studies involving meaningful collaboration between faculty focused on basic, clinical, or population-based research in substance use disorders. Specifically, collaboration between a basic science and a clinical investigator, a clinical investigator and a population science investigator, or a basic science and a population science investigator. The two major goals of this pilot RFA are to expand collaborations and to make research investments that maximize healthcare value and improve health.
The immediate aim for these pilot funds is to allow investigators to develop, test, or disseminate novel approaches to a translational research question and obtain preliminary data in support of larger follow-up investigations. Examples of pilot studies include feasibility studies, secondary analysis of existing data, development of new research methodology and/or new tools, dissemination of effective tools, methods, processes, or early development of new therapy/technology. Priority will be given to junior faculty and investigators who envision using the pilot data for future extramural funding.
Additional details are available in the RFA. Applications should be submitted through the ePilot electronic submission system. Questions about the ePilot electronic submission system should be directed to Katelyn Still.
Full Application Deadline: December 8, 2024 at 11:59PM ET
Common Deadline Pilot RFAs
Take advantage of the many funding opportunities with the December 13th Common Deadline.
Review the linked RFAs to learn more and apply today!
Center RFA | Full Application Deadline | Application Link | Award Amount |
12/13/2024 by 11:59PM ET |
Apply Now | $40,000 | |
12/13/2024 by 11:59PM ET |
Apply Now | $30,000 | |
Center for Artificial Intelligence (CAIR) |
12/13/2024 by 11:59PM ET |
Apply Now | $40,000 |
Wake Forest Innovations Commercialization Pathway Award Request for Projects
The mission of Wake Forest Innovations is to translate research into beneficial products and services. The Commercialization Pathway Award furthers this mission by supporting members of the Wake Forest community by awarding financial support for milestone-driven commercially relevant projects in which the institution has a proprietary position. Projects should be designed to advance the intellectual property and commercial and licensable potential of technologies.
Examples of suitable projects include advanced proof-of-concept and feasibility studies, studies that enable go/no-go commercialization decisions, and studies designed to exceed commercially relevant value inflection points. Successful projects will receive up to $40,000 in direct costs, to be spent within a one-year project period.
Applications should fall into one of the following areas:
- Therapeutic/drug/biologic
- Diagnostic/Medical device
- Digital health
- Other (please describe)
These awards are open to investigators across Advocate Health. This includes Atrium Health, Atrium Health Navicent, and Atrium Health Wake Forest Baptist, including Wake Forest University School of Medicine. Wake Forest University (Reynolda Campus) faculty are also encouraged to apply. Additional details are available in the RFP. To apply, click here.
Deadline: Monday, December 23, 2024 by 11:59PM ET
Research Centers
An Institutionally-Supported Research Center is an interdepartmental unit focused predominantly on translational, clinical and/or basic science research which facilitates development of a common, focused research agenda aligned with strategic priorities, coordinating contributions from multiple disciplines (other centers, divisions/departments, and programs). We are pleased to announce the following opportunities are now available:
- Research Centers – The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Research Center. This document also provides the framework for a renewal application of an existing center. Research Centers support mature areas of research that reflect depth in translational, clinical and/or basic science research. View the full RFA for Research Centers here.
- Emerging Research Centers - The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Emerging Research Center. This document also provides the framework for a renewal application of an existing center. Emerging Research Centers support new ideas in need of investment for growth. The investment is intended to catalyze the formation of a team for the specific purpose of developing a strategic vision in order to grow a critical base of extramurally funded research. This research can be established in translational, clinical and/or basic science research. View the full RFA for Emerging Research Centers here.
Direct questions and applications to Lynne Wagenknecht, Vice Dean for Population Health Research, and/or Lindsay Trost, CTSI Administrative Director.
Foundation
Interested applicants may contact the Foundations Relations team at foundations@wakehealth.edu.
Cancer | American Brain Tumor Association - Brain Tumor Funders' Collaborative | Liquid Biopsy for Primary Brain Tumors LOI |
$500,000 | 1/16/2025 |
Varied | Burroughs Wellcome Fund | Climate Change and Human Health Seed Grants |
$50,000 | 1/23/2025 |
Rheumatology | Arthritis National Research Foundation | 2025 All Arthritis Research Grant Application |
$250,000 | 1/24/2025 |
Chan Zuckerberg Initiative's Science Diversity Leadership Award
The Science Diversity Leadership Award (SDLA) from the Chan Zuckerberg Initiative (CZI) will support Principal Investigators who are outstanding early- to mid-career biomedical researchers at U.S. universities, medical schools, or nonprofit research institutes who—through their outreach, mentoring, teaching, and leadership—have a record of promoting diversity, equity, and inclusion (DEI) in their scientific communities. They will have made significant research contributions to the biomedical sciences, show promise for continuing scientific achievement, and demonstrate leadership in efforts to diversify the sciences. CZI is committed to supporting representative science, which ensures universal benefits from scientific advances, such as studies of diseases that adversely affect underserved populations from specific ancestries and promotes diversity among researchers toward more inclusive and comprehensive outcomes. Applicants will perform research related broadly to biomedical sciences. Preference will be given to research programs that align with CZI Science and/or programs with diversity as a research component. Part of the applicant's evaluation will include their research contributions and current research program. Note: Clinical trials and public health research are out of scope for this award.
Those interested in applying may reach out to the Foundation Relations Team for assistance throughout the proposal process and can also reach out to the foundation with any questions on behalf of faculty. Additional details are available in the RFA.
Application Deadline: December 3, 2024
NIH
- RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
- PAR-23-240: Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Professional Associations and Societies
Please refer to the individual Program or Funding Opportunity Announcement for deadline information.
- American Cancer Society
- The Triological Society
- American Heart Association
- American Gastroenterological Association
- American Federation for Aging Research
- Alzheimer's Association
- ALS Association
- American Diabetes Association
- Juvenile Diabetes Research Foundation
- Thoracic Surgery Foundation for Research and Education
- Society for Pediatric Dermatology
Other Opportunities
All of Us Research Program
All of Us Research Program Seeks Engagement and Enrollment Partners: The National Institutes of Health's All of Us Research Program has issues a new funding opportunity soliciting proposals to support outreach, community engagement and participant enrollment and retention efforts. The opportunity spans four specific areas of interest, including community, participant and health care provider engagement, enrollment and retention; researcher engagement; Tribal engagement; and integration of participants and advocates in program oversight.
• Proposals will be accepted on an ongoing basis through May 23, 2025
• Read the Full Announcement
NeuroNEXT Grant
The NeuroNEXT Network is designed to efficiently conduct Phase II Clinical Trials. NeuroNEXT Network is now accepting proposals. Applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies are encouraged. Successful applicants will be given access to the NeuroNEXT infrastructure to support the efficient implementation of the proposed study at multiple sites and statistical and data management.
If you are interested, please schedule a meeting to discuss your proposal with the NeuroNEXT Study Team. This opportunity is ongoing until 2028.
- Benefits of Partnering with NeuroNEXT
- Applying for a NeuroNEXT Grant
- Contact: Mysha Sissine, Program Manager
Additional Resources
Listed below are some quick ways to find external funding opportunities through search mechanisms and announcement listservs.
Additional Resources
- For detailed information on funding opportunities, search www.grants.gov with keywords related to your research interests.
- National Institutes of Health (NIH)
- NIH Career Development Awards (K-Series)
- Patient-Centered Outcomes Research Institute (PCORI)
- Health Resources and Services Administration (HRSA)
- National Science Foundation (NSF)
- North Carolina Biotechnology Center